The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Sp572
ROLE OF PROMOTILITY AGENTS IN UGI MOTILITY DISORDERS
Date
May 19, 2024
Explore related products in the following collection:
BACKGROUND: As outlined by the Kyoto guidelines, targeted DNA-based NGS of pancreatic cyst fluid (PCF) is an important adjunct to the evaluation of pancreatic cyst patients…
LIVE STREAM SESSION DDW attendees will hear expert opinions on controversial topics in the challenging clinical care of Neurogastroenterology. Attendees can decide which position works best for their clinical care…
BACKGROUND: Recent studies suggest links between _Clostridioides difficile_ infection (CDI) and liver disorders, with non-alcoholic fatty liver disease (NAFLD) increasing CDI risk and CDI exacerbating the progression and prognosis of liver cirrhosis. Moreover, gut dysbiosis, often leading to _C…